Drug
Talactoferrin
Talactoferrin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_3
2
40%
Ph phase_1
3
60%
Phase Distribution
3
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Terminated(1)
Other(2)
Detailed Status
unknown2
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 13 (60.0%)
Phase 32 (40.0%)
Trials by Status
unknown240%
terminated120%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer
NCT00923741
terminatedphase_1
Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
NCT01528137
completedphase_3
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
NCT00707304
unknownphase_3
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
NCT00706862
unknownphase_1
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
NCT00854633
Clinical Trials (5)
Showing 5 of 5 trials
NCT00923741Phase 1
Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer
NCT01528137Phase 1
Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
NCT00707304Phase 3
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
NCT00706862Phase 3
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
NCT00854633Phase 1
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5